New Indian Multinational Pharma Private Limited - Company Profile

It is a chemicals private limited company based in Mumbai, Maharashtra, India, established in 2008.
2008 Mumbai, Maharashtra, India Struck Off
Last Updated:
Access Report
About New Indian Multinational Pharma Private Limited

New Indian Multinational Pharma Private Limited, a struck off private limited company, was established on 26 August 2008 in Mumbai, Maharashtra, India. Engaging in other chemical product within the chemicals sector, it holds CIN: U24232MH2008PTC186168. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M.

Its leadership includes Hidayat Hamidullah Khan (Managing Director), Saleha Subura Hidayat Khan (Additional Director). Past directors included Mohd Anis Iqbal Nek. It is based at Shop No. 36, Pioneer Heritage Residency Ii, Ground Floor, Off. S. V. Road, Santacruz, (West), Mumbai, Maharashtra, 400054.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232MH2008PTC186168

  • Registration Number

    186168

  • Incorporation Date

    26 August 2008

  • Authorized Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Struck Off

Key Metrics
  • Authorised Capital ₹ 0.50 M
  • Company Age 17 Year, 6 Months
Company report

New Indian Multinational Pharma Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into New Indian Multinational Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at New Indian Multinational Pharma Private Limited?
Current Directors
Name Designation Appointment Date Status
Hidayat Hamidullah Khan Managing Director 26 Aug 2008 Current
Saleha Subura Hidayat Khan Additional Director 03 Oct 2009 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 04 Oct 2009 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of New Indian Multinational Pharma.

Enhance accessibility to New Indian Multinational Pharma's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

New Indian Multinational Pharma revenue growth over time
New Indian Multinational Pharma profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of New Indian Multinational Pharma?

Unlock access to New Indian Multinational Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at New Indian Multinational Pharma?

Unlock and access historical data on people associated with New Indian Multinational Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of New Indian Multinational Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped New Indian Multinational Pharma's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on New Indian Multinational Pharma
Recent Activity within the Organization
  • Director Appointment

    Progress on Saleha Subura Hidayat Khan was appointed as a Additional Director was appointed as a Additional Director on 03 Oct 2009 & has been associated with this company since 16 years 4 months . was documented.

  • Director Appointment

    Progress on Hidayat Hamidullah Khan was appointed as a Managing Director was appointed as a Managing Director on 26 Aug 2008 & has been associated with this company since 17 years 6 months . was documented.

  • Company Incorporation

    The activity New Indian Multinational Pharma Private Limited was registered on 26 Aug 2008 with Roc Mumbai & aged 17 years 6 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of New Indian Multinational Pharma Private Limited?

The CIN of New Indian Multinational Pharma Private Limited is U24232MH2008PTC186168.

Where is New Indian Multinational Pharma Private Limited headquartered?

New Indian Multinational Pharma Private Limited is headquartered at Shop No. 36, Pioneer Heritage Residency Ii, Ground Floor, Off. S. V. Road, Santacruz, (West), Mumbai, Maharashtra, 400054.

When was New Indian Multinational Pharma Private Limited incorporated?

New Indian Multinational Pharma Private Limited was incorporated on 26 August 2008.

Who are the current directors of New Indian Multinational Pharma Private Limited?

The current directors of New Indian Multinational Pharma Private Limited are

What is the primary industry of New Indian Multinational Pharma Private Limited?

The primary industry of New Indian Multinational Pharma Private Limited is Chemicals.

Is New Indian Multinational Pharma Private Limited a listed company?

New Indian Multinational Pharma Private Limited is unlisted.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available